IRON, AMINO ACIDS WITH VITAMIN-B COMPLEX CAPSULES.
Astyfer capsules contain the 3 AMINO ACIDS important in the formation of Haemoglobin namely – Glycine, Histidine & Lysine. These AMINO ACIDS are also reported to enhance iron absorption from the intestines. All other haemopoietic factors such as Iron, Vitamins B1, B2, B6, B12, C and Folic Acid are present making Astyfer the comprehensive haemonutrient. Astyfer is manufactured using Marumerisation Technology which ensures that there is no drug dumping, thereby minimising the chances of gastric irritation.
Each Capsule contains:
Ferrous fumarate BP 150 mg (Equivalent to elemental iron 49 mg)
L-histidine hydrochloride H2O BP 4 mg – L-Iysine hydrochloride USP 25 mg
Glycine USP 10mg – Thiamine nitrate BP 5mg – Riboflavin BP 3 mg
Pyridoxine hydrochloride BP 1.5 mg – Cyanocobalamin BP 2.5 mcg
Folic acid BP 0.5 mg – Ascorbic acid BP 40 mg
Indigo Carmine, Carmoisine
INDICATIONS AND USAGE
Astyfer is indicated in the treatment of many of the common iron deficiency anaemia, particularly those associated with nutritional deficiency states or when nutritional requirements are high. These iron deficiency states include anaemia associated with dietary inadequacy, convalescence, those frequently encountered in late childhood, early adolescence, and old age, and the anaemia of women from menarche to menopause including macrocytic or microcytic anaemia of pregnancy.
Iron deficiency may result in fatigue, palpitation, smooth and sore tongue, angular stomatitis, dysphagia, gastritis, enteropathy as well as anaemia.
DOSAGE AND ADMINISTRATION
The usual dose is one capsule twice a day or as directed by physician.
Dosage may be adjusted according to the response of the patient.
Hemochromatosis and hemosiderosis are contraindications to iron therapy.
Not intended for treatment of pernicious anaemia or other megaloblastic anaemia where vitamin B12 is deficient.
Since oral iron products interfere with absorption of oral tetracycline, these products should not be taken within two hours of each other.
Neomycin and colchicine may impair cyanocobalamin absorption.
Phenytoin, methotrexate, and pyrimethamine may interfere with folic acid absorption.
Pyridoxine hydrochloride may act as an antagonist to levodopa.
Allergic reactions, skin rashes, and gastrointestinal disturbances, such as nausea, vomiting, diarrhoea, or constipation may occur.
Allergic sensitization has been reported on administration of folic acid.
SIDE-EFFECTS AND SPECIAL PRECAUTIONS
The oral administration of iron preparations sometimes produces gastrointestinal irritation with vomiting and diarrhoea. Continued administration may sometimes produce constipation. The faeces of patients taking iron supplements may be black in colour.
KNOWN SYMPTOMS OF OVERDbSAGE AND PARTICULARS OF ITS TREATMENT
Initially epigastric pain, diarrhoea and vomiting; and may include metabolic acidosis, convulsions, and coma after apparent recovery.
Speed is essential for effective treatment which is dependent upon removing excess iron from the alimentary tract prior to absorption. Initially an emetic should be given, followed by gastric lavage with 1% sodium bicarbonate, and oral administration of desferrioxamine to complex with residue.
Fluid loss may be corrected with IV normal saline or dextrose solution.
Blister pack of 2 x 15 capsules with individual carton.
Store below 30°C. Protect from direct sunlight.
Keep all medicines out of reach and sight of young children
Imported and Marketed by
Fidson Healthcare Plc
268 Ikorodu Road, Obanikoro, Lagos, Nigeria.
Made in India by
TIL HEALTHCARE PVT LTD
100, Sri City SEZ, Irugulam Post,
Andhra Pradesh – 517 588, India.